Adamis announces merger four months after PhII/III miss
In a bid to stay afloat, Adamis Pharmaceuticals will merge with DMK Pharmaceuticals. The merger comes just four months after its stock crashed following …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
